Suchergebnisse

Nissan Motor Co., Ltd. NSANY has reached a significant milestone in its push toward next-generation EV technology, targeting the launch of its first vehicles equipped with all-solid-state batteries

In the latest trading session, Target (TGT) closed at $130.18, marking a +1.83% move from the previous day. The stock outpaced the S&P 500's daily loss of 0.24%. On the other hand, the Dow

Target (TGT) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near

Investment banker Goldman Sachs recently raised its price target for UnitedHealth Group Incorporated (UNH) shares from $400 to $435, citing the company’s increased full-year guidance, announced in

Target (TGT) closed at $127.13 in the latest trading session, marking a -2% move from the prior day. This move lagged the S&P 500's daily loss of 0.49%. Elsewhere, the Dow saw a downswing of 0.05%

Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report? It is worth considering Target (TGT), which belongs to the Zacks Retail

Aura Biosciences, Inc. (AURA) closed the last trading session at $7.29, gaining 11.3% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set

Chewy (CHWY) closed the last trading session at $27.52, gaining 17.8% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street

Shares of nCino (NCNO) have gained 21.5% over the past four weeks to close the last trading session at $18.46, but there could still be a solid upside left in the stock if short-term price targets

Abercrombie & Fitch (ANF) closed the last trading session at $94.36, gaining 7.3% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by

Draganfly Inc. (DPRO) closed the last trading session at $5.94, gaining 5% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall

ANI Pharmaceuticals ANIP has been steadier than its broader sector this year, but it has not fully kept pace with its closest peer set. Shares are up 2.5% year to date, versus a 3.5% gain for the

ANI Pharmaceuticals ANIP is reshaping its growth profile around specialty medicines, with Cortrophin Gel increasingly driving results and management’s 2026 targets. Fiscal 2025 also underscored how

Solaris Energy Infrastructure SEI is at a decision point near $65, with a 6–12 month price target of $70 that frames modest upside over the next year. That same 6–12 month outlook implies

Colliers International (CIGI) closed the last trading session at $117.75, gaining 15.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets

Progress Software (PRGS) closed the last trading session at $31.32, gaining 0.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by